中国制药与生物科技政策逆风及其对估值的影响(英)-20页.docxVIP

  • 1
  • 0
  • 约3.3万字
  • 约 19页
  • 2026-07-08 发布于湖南
  • 举报

中国制药与生物科技政策逆风及其对估值的影响(英)-20页.docx

18June2026

ChinaPharmaandBiotech

ChinaPharmaBiotech:Policyheadwindsandimplicationsforvaluation

WereviewrecentUSandChinapolicies-atriggeroftherecenthealthcaresell-off-andestimatethepotentialimpactoninnovativedrugmakersinthisnote.

USpoliciesandlegislativeefforts(BiosecureAct,COINS/BINSA)increasinglytargetthe

fullstack:capitalflows,dataaccess,licensing,andsupplychains.Whileimplementation

remainsstaged,thedirectionisunambiguousandcallsforreducedUScapital

participation,tighterscrutinyoncross-borderdeals,andrisingfrictioni

文档评论(0)

1亿VIP精品文档

相关文档